Real-world outcomes with immuno-oncology (IO) therapies: A prospective, observational cohort study in patients (pts) with advanced melanoma (OPTIMIzE).

被引：0
|
作者：
Kirkwood, John M.
Kottschade, Lisa A.
McWilliams, Robert R.
Khushalani, Nikhil I.
Jang, Sekwon
Hallmeyer, Sigrun
McDermott, David F.
Tawbi, Hussein Abdul-Hassan
Wan, Yin
Wang, Rosa
Ritchings, Corey
Rao, Sumati
Ramsey, Scott
机构：
[1] Univ Pittsburgh, Melanoma Program, UPMC Hillman Canc Ctr, Pittsburgh, PA USA
[2] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
[3] Mayo Clin, Rochester, MN USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[5] Virginia Commonwealth Univ, Inova Schar Canc Inst, Fairfax, VA USA
[6] Advocate Med Grp, Park Ridge, IL USA
[7] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[9] Bristol Myers Squibb, Princeton, NJ USA
[10] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e14144
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14144
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Real-world outcomes of advanced melanoma patients not represented in phaseIIItrials
    van Zeijl, Michiel C. T.
    Ismail, Rawa K.
    de Wreede, Liesbeth C.
    van den Eertwegh, Alfonsus J. M.
    de Boer, Anthonius
    van Dartel, Maaike
    Hilarius, Doranne L.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Boers-Sonderen, Marye J.
    de Groot, Jan-Willem B.
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Piersma, Djura
    van Rijn, Rozemarijn S.
    Suijkerbuijk, Karijn P. M.
    ten Tije, Albert J.
    van der Veldt, Astrid A. M.
    Vreugdenhil, Gerard
    Haanen, John B. A. G.
    Wouters, Michel W. J. M.
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (12) : 3461 - 3470
  • [22] Real World Immuno-oncology Treatment Patterns and Outcomes in US Patients with Metastatic Head and Neck Cancer
    Bell, K.
    Bruno, A.
    Stafkey, D.
    Murty, S.
    Ballas, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1161 - 1161
  • [23] Characteristics and treatment patterns of patients with advanced or metastatic non-small cell lung cancer managed with first-line immuno-oncology strategies in Greece: Interim results of a real-world prospective study (IO-HORIZON)
    Linardou, H.
    Charpidou, A.
    Koumarianou, A.
    Mountzios, G.
    Kosmidis, P. A.
    Christodoulou, C.
    Mavroudis, D.
    Christopoulou, A. N.
    Korantzis, I.
    Baka, S.
    Vaslamatzis, M.
    Athanasiadis, I.
    Koutras, A.
    Mauri, D.
    Kotsakis, A.
    Ziogas, D.
    Desiniotis, A.
    Dimitriadis, I.
    Syrigos, K.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S69 - S70
  • [24] Real-world Frequency of BRAF Testing and Utilization of Therapies in Patients with Advanced Melanoma
    Hill, M. V.
    Deng, M.
    Handorf, E.
    Olszanski, A. J.
    Farma, J. M.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S108 - S108
  • [25] Real-world frequency of BRAF testing and utilization of therapies in patients with advanced melanoma
    Hill, Maureen, V
    Vidri, Roberto J.
    Deng, Mengying
    Handorf, Elizabeth
    Olszanski, Anthony J.
    Farma, Jeffrey M.
    MELANOMA RESEARCH, 2022, 32 (02) : 79 - 87
  • [26] Real-world immuno-oncology treatment patterns and outcomes in US patients with metastatic non-small-cell lung cancer.
    Bruno, Amanda
    Bell, Kelly
    Stafkey-Mailey, Dana
    Murty, Sharanya
    Ballas, Marc S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] REAL-WORLD OUTCOMES OF NOVEL TREATMENTS IN PATIENTS WITH ADVANCED MELANOMA IN THE NETHERLANDS
    Leeneman, B.
    Franken, M.
    Jochems, A.
    Schouwenburg, M.
    Aarts, M.
    van Akkooi, A.
    van den Berkmortel, F.
    van den Eertwegh, A.
    Groenewegen, G.
    de Groot, J.
    Haanen, J.
    Hospers, G.
    Kapiteijn, H.
    Koornstra, R.
    Kruit, W.
    Louwman, M.
    Piersma, D.
    van Rijn, R.
    ten Tije, A.
    Vreugdenhil, G.
    Wouters, M.
    van Zeijl, M.
    van der Hoeven, J.
    Uyl-de Groot, C.
    VALUE IN HEALTH, 2016, 19 (07) : A709 - A709
  • [28] REAL WORLD OUTCOMES IN PATIENTS WITH ADVANCED/METASTATIC SOLID TUMORS WHO ARE IMMUNO-ONCOLOGY (IO) NAIVE AND RECEIVED SECOND-LINE THERAPY: ANALYSIS BY TUMOR MUTATIONAL BURDEN (TMB) STATUS
    Gogate, A.
    Palaia, J.
    Zhang, Y.
    You, M.
    Sama, A.
    VALUE IN HEALTH, 2022, 25 (12) : S470 - S470
  • [29] Prospective, multinational, observational study of real-world treatment outcomes with pazopanib in patients with advanced or metastatic renal cell carcinoma (PRINCIPAL study).
    Schmidinger, Manuela
    Procopio, Giuseppe
    Hawkins, Robert E.
    Sanchez, Angel Rodriguez
    Vazquez, Sergio
    Srihari, Narayanan
    Kalofonos, Haralabos
    Bamias, Aristotelis
    Bono, Petri
    Pisal, Chaitali Babanrao
    Hirschberg, Yulia
    Dezzani, Luca
    Ahmad, Qasim Iftikhar
    Jonasch, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [30] Patient-Reported Distress and Clinical Outcomes with Immuno-Oncology Agents in Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Real-World Retrospective Cohort Study
    Bodd, Monica H.
    Locke, Susan C.
    Wolf, Steve P.
    Antonia, Scott
    Crawford, Jeffrey
    Hartman, John
    Herring, Kris W.
    Ready, Neal E.
    Stinchcombe, Thomas E.
    Troy, Jesse D.
    Williams, Chakita
    Clarke, Jeffrey M.
    LeBlanc, Thomas W.
    LUNG CANCER, 2023, 175 : 17 - 26
12345